— Know what they know.
Not Investment Advice

ONWD.BR

Onward Medical N.V.
1W: -3.6% 1M: -14.4% 3M: -13.6% YTD: -18.4% 1Y: -40.1% 3Y: -29.6%
€3.47 ($4.01)
+0.00 (+0.14%)
 
BRU · Healthcare · Biotechnology · €154.9M · Alpha Radar Sell · Power 35
Smart Money Score
No convergence signal
Key Statistics
Market Cap€154.9M ($179.1M)
52W Range3.455-5.77
Volume83,175
Avg Volume130,193
Beta0.89
Dividend
Analyst Ratings
No analyst coverage
Company Info
CEODavid L. Marver
Employees102
SectorHealthcare
IndustryBiotechnology
IPO Date2021-10-21
Websiteonwd.com
High Tech Campus 32
Eindhoven 5656 AE
NL
About Onward Medical N.V.

Onward Medical N.V., a medical technology company, focuses on developing therapies for spinal cord injuries in the Netherlands and internationally. The company engages in developing ARCEX, an external non-invasive platform that consists of a wearable stimulator and wireless programmer, which restores or enhances physical movement of hand and arm function to people with spinal cord therapy; and ARCIM, an implantable platform, which consists of an implantable pulse generator and lead that is placed near the spinal cord that enables long-paralyzed people to stand and walk again with little or no assistance. It also engages in developing Up-LIFT Trial to evaluate the safety and effectiveness of ARCEX Therapy in restoring strength and function of upper extremities in people with spinal cord injury. Onward Medical N.V. was founded in 2014 and is headquartered in Eindhoven, Netherlands.

Recent Insider Trades

No insider trades found

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms